NCT03554707 2022-02-08
SGT-53 in Children With Recurrent or Progressive CNS Malignancies
SynerGene Therapeutics, Inc.
Phase EARLY_PHASE1 Unknown
SynerGene Therapeutics, Inc.
Leaf Vertical Inc.
Seoul National University Hospital
Medical University Innsbruck
Grupo Español de Investigación en Neurooncología
Adnexus, A Bristol-Myers Squibb R&D Company